A new step towards an HIV/AIDS vaccine

Affiliations

¹ Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute Frederick, MD 21702-1201, USA. Electronic address: george.pavlakis@nih.gov.
² Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute Frederick, MD, USA.

Comment

George N Pavlakis et al. Lancet. 2018.

. 2018 Jul 21;392(10143):192-194.

doi: 10.1016/S0140-6736(18)31548-4. Epub 2018 Jul 6.

¹ Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute Frederick, MD 21702-1201, USA. Electronic address: george.pavlakis@nih.gov.
² Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute Frederick, MD, USA.

No abstract available

Comment on

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, Michael NL, Peter L, Nkolola JP, Borducchi EN, Chandrashekar A, Jetton D, Stephenson KE, Li W, Korber B, Tomaras GD, Montefiori DC, Gray G, Frahm N, McElrath MJ, Baden L, Johnson J, Hutter J, Swann E, Karita E, Kibuuka H, Mpendo J, Garrett N, Mngadi K, Chinyenze K, Priddy F, Lazarus E, Laher F, Nitayapan S, Pitisuttithum P, Bart S, Campbell T, Feldman R, Lucksinger G, Borremans C, Callewaert K, Roten R, Sadoff J, Scheppler L, Weijtens M, Feddes-de Boer K, van Manen D, Vreugdenhil J, Zahn R, Lavreys L, Nijs S, Tolboom J, Hendriks J, Euler Z, Pau MG, Schuitemaker H. Barouch DH, et al. Lancet. 2018 Jul 21;392(10143):232-243. doi: 10.1016/S0140-6736(18)31364-3. Epub 2018 Jul 6. Lancet. 2018. PMID: 30047376 Free PMC article. Clinical Trial.